ImpriMed, Inc.
BioTech/Drugs - Palo Alto, CA, US
ImpriMed, Inc. Senior Management
ImpriMed, Inc. Details
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases. ImpriMed's key product, Chemo Response Prediction Service has been used by board-certified veterinary oncologists, helping over 2,000 dogs with lymphoma and leukemia. With ImpriMed's services, veterinarians make their treatment decisions quickly and with confidence. This innovative approach to cancer care has been published in a scientific journal and presented at major conferences and is supported by over 150 veterinary oncologists at 80+ specialty hospitals in the US.
Website:
imprimedicine.com
Employees:
20 - 49
HQ:
N/A
Location:
Palo Alto, CA, US
Revenue:
2.5 - 5 Million
ImpriMed, Inc. Technologies
Email Providers
Gmail
Widgets
Facebook Widget
Domain Name Services
Route 53
Other
Mobile Friendly
Hosting
Amazon AWS